2 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 1 | 1 | Recruiting 1 |
Follow CTX-471: new trials by email Literature Review of CTX-471 trials Research Report on CTX-471
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of CTX-471 in Patients With Neural Cell Adhesion Molecule (NCAM) Positive Neuroendocrine Neoplasms CTX-471 - Neuroendocrine Neoplasm, Neuroendocrine Carcinomas | Phase 2 | Recruiting | Compass Therapeutics | 58 | 2026-11-01 | 2026-11-09 |
| Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma CTX-009, CTX-471 - Glioblastoma | Phase 1 / Phase 2 | Recruiting | Washington University School of Medicine | 54 | 2026-06-16 | 2026-06-22 |
Carcinoma, Neuroendocrine (1) · Glioblastoma (1) · Neuroendocrine Tumors (1)
Compass Therapeutics (1) · Washington University School of Medicine (1)
United States (2)